FDA warning for terbutaline in preterm labor
The U.S. Food and Drug Administration issued a warning that terbutaline, indicated for asthma, bronchitis, and emphysema, should not be used in pregnant women…
Women’s Health
FDA approves drug to reduce risk of preterm birth
The U.S. Food and Drug Administration (FDA) has approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery in pregnant women with…
FDA advises women with breast impants
The U.S. Food and Drug Administration says women with breast implants may have a “very small, but increased risk” of developing anaplastic large cell…
Do you know which vaccines are recommended for special populations?
Pregnant and postpartum women, immunocompromised children, and persons at high risk for flu-related complications have special immunization needs. Part of ANA’s Bringing Immunity to…
FDA recommends removing Avastin’s breast cancer indication
The U.S. Food and Drug Administration (FDA) is recommending that the breast cancer indication for Avastin be removed from its label “because the drug…
Postpartum depression: Don’t let patients suffer in silence
This might come as a surprise, but postpartum depression (PPD) is the number-one complication of childbearing. Experts estimate it strikes at least one in…
What every nurse needs to know about breast cancer
Breast cancer strikes 1 in 8 American women. This article discusses recent diagnostic and treatment advances (including some you may not know about) that…
Polycystic ovary syndrome: A threat to appearance, menstruation, and fertility
Affecting 1 in 10 U.S. females, this distressing condition can be treated, though not cured. Your compassionate care and on-point teaching can make a…
Risks pf BSGI and PEM studies
According to a study in Radiology, a single breast-specific gamma imaging (BSGI) or positron emission mammography (PEM) test is “associated with a fatal radiation-induced…
Avastin may lose metastatic breast cancer indication
An U.S. Food and Drug Administration (FDA)-advisory panel has voted to strip Avastin’s indication for metastatic breast cancer because the drug is not effective…
In some situations, axillary node removal doesn’t improve breast cancer survival
A study presented at the American Society of Clinical Oncology June meeting found that removing additional axillary lymph nodes to look for breast cancer…
FDA approves new drug for osteoporosis
On June 1, the U.S. Food and Drug Administration (FDA) approved Prolia (denosumab), an injectable treatment for postmenopausal women with osteoporosis who are at…
FDA warning for terbutaline in preterm labor
The U.S. Food and Drug Administration issued a warning that terbutaline, indicated for asthma, bronchitis, and emphysema, should not be used in…
FDA approves drug to reduce risk of preterm birth
The U.S. Food and Drug Administration (FDA) has approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery in pregnant…
FDA advises women with breast impants
The U.S. Food and Drug Administration says women with breast implants may have a “very small, but increased risk” of developing anaplastic…
Do you know which vaccines are recommended for special populations?
Pregnant and postpartum women, immunocompromised children, and persons at high risk for flu-related complications have special immunization needs. Part of ANA’s Bringing…
FDA recommends removing Avastin’s breast cancer indication
The U.S. Food and Drug Administration (FDA) is recommending that the breast cancer indication for Avastin be removed from its label “because…
Postpartum depression: Don’t let patients suffer in silence
This might come as a surprise, but postpartum depression (PPD) is the number-one complication of childbearing. Experts estimate it strikes at least…
What every nurse needs to know about breast cancer
Breast cancer strikes 1 in 8 American women. This article discusses recent diagnostic and treatment advances (including some you may not know…
Polycystic ovary syndrome: A threat to appearance, menstruation, and fertility
Affecting 1 in 10 U.S. females, this distressing condition can be treated, though not cured. Your compassionate care and on-point teaching can…
Risks pf BSGI and PEM studies
According to a study in Radiology, a single breast-specific gamma imaging (BSGI) or positron emission mammography (PEM) test is “associated with a…
Avastin may lose metastatic breast cancer indication
An U.S. Food and Drug Administration (FDA)-advisory panel has voted to strip Avastin’s indication for metastatic breast cancer because the drug is…
In some situations, axillary node removal doesn’t improve breast cancer survival
A study presented at the American Society of Clinical Oncology June meeting found that removing additional axillary lymph nodes to look for…
FDA approves new drug for osteoporosis
On June 1, the U.S. Food and Drug Administration (FDA) approved Prolia (denosumab), an injectable treatment for postmenopausal women with osteoporosis who…
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.